These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39121557)

  • 1. Unraveling the Link: Seizure Characteristics and Ammonia Levels in Urea Cycle Disorder During Hyperammonemic Crises.
    Chanvanichtrakool M; Schreiber JM; Chen WL; Barber J; Zhang A; Ah Mew N; Schulze A; Wilkening G; Nagamani SCS; Gropman A;
    Pediatr Neurol; 2024 Oct; 159():48-55. PubMed ID: 39121557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder.
    Lee B; Diaz GA; Rhead W; Lichter-Konecki U; Feigenbaum A; Berry SA; Le Mons C; Bartley JA; Longo N; Nagamani SC; Berquist W; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Cederbaum S; Wong D; Merritt JL; Schulze A; Vockley J; Kronn D; Zori R; Summar M; Milikien DA; Marino M; Coakley DF; Mokhtarani M; ; Scharschmidt BF
    Genet Med; 2015 Jul; 17(7):561-8. PubMed ID: 25503497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine and hyperammonemic crises in patients with urea cycle disorders.
    Lee B; Diaz GA; Rhead W; Lichter-Konecki U; Feigenbaum A; Berry SA; Le Mons C; Bartley J; Longo N; Nagamani SC; Berquist W; Gallagher RC; Harding CO; McCandless SE; Smith W; Schulze A; Marino M; Rowell R; Coakley DF; Mokhtarani M; Scharschmidt BF
    Mol Genet Metab; 2016 Jan; 117(1):27-32. PubMed ID: 26586473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of EEG monitoring in neonates with hyperammonemia due to inborn errors of metabolism.
    Wiwattanadittakul N; Prust M; Gaillard WD; Massaro A; Vezina G; Tsuchida TN; Gropman AL
    Mol Genet Metab; 2018 Nov; 125(3):235-240. PubMed ID: 30197275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders.
    McGuire PJ; Lee HS; ; Summar ML
    J Pediatr; 2013 Dec; 163(6):1705-1710.e1. PubMed ID: 24084106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.
    Berry SA; Lichter-Konecki U; Diaz GA; McCandless SE; Rhead W; Smith W; Lemons C; Nagamani SC; Coakley DF; Mokhtarani M; Scharschmidt BF; Lee B
    Mol Genet Metab; 2014 May; 112(1):17-24. PubMed ID: 24630270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders.
    Longo N; Diaz GA; Lichter-Konecki U; Schulze A; Inbar-Feigenberg M; Conway RL; Bannick AA; McCandless SE; Zori R; Hainline B; Ah Mew N; Canavan C; Vescio T; Kok T; Porter MH; Berry SA
    Mol Genet Metab; 2021 Jan; 132(1):19-26. PubMed ID: 33388234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders.
    Meyburg J; Opladen T; Spiekerkötter U; Schlune A; Schenk JP; Schmidt J; Weitz J; Okun J; Bürger F; Omran TB; Abdoh G; Al Rifai H; Monavari A; Konstantopoulou V; Kölker S; Yudkoff M; Hoffmann GF
    J Inherit Metab Dis; 2018 Jan; 41(1):81-90. PubMed ID: 29027067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on urea cycle disorder management: Results of a clinician survey.
    Enns GM; Porter MH; Francis-Sedlak M; Burdett A; Vockley J
    Mol Genet Metab; 2019; 128(1-2):102-108. PubMed ID: 31377149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical findings of patients with hyperammonemia affected by urea cycle disorders with hepatic encephalopathy.
    Lopes FF; Sitta A; de Moura Coelho D; Ribas GS; Faverzani JL; Dos Reis BG; Wajner M; Vargas CR
    Int J Dev Neurosci; 2022 Dec; 82(8):772-788. PubMed ID: 36129623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of adjunct therapeutic hypothermia treatment for hyperammonemia and encephalopathy due to urea cycle disorders and organic acidemias.
    Lichter-Konecki U; Nadkarni V; Moudgil A; Cook N; Poeschl J; Meyer MT; Dimmock D; Baumgart S
    Mol Genet Metab; 2013 Aug; 109(4):354-9. PubMed ID: 23791307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between longitudinal changes in neuropsychological outcome and disease biomarkers in urea cycle disorders.
    Lichter-Konecki U; Sanz JH; ; McCarter R
    Pediatr Res; 2023 Dec; 94(6):2005-2015. PubMed ID: 37454183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset urea cycle disorder in adulthood unmasked by severe malnutrition.
    Wells DL; Thomas JB; Sacks GS; Zouhary LA
    Nutrition; 2014; 30(7-8):943-7. PubMed ID: 24985015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of adult patients with noncirrhotic hyperammonemia.
    Stergachis AB; Mogensen KM; Khoury CC; Lin AP; Peake RW; Baker JJ; Barkoudah E; Sahai I; Sweetser DA; Berry GT; Krier JB
    J Inherit Metab Dis; 2020 Nov; 43(6):1165-1172. PubMed ID: 32713002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of 85 patients with urea cycle disorders: one center experience, three new mutations.
    Saritaş Nakip Ö; Yıldız Y; Tokatlı A
    J Pediatr Endocrinol Metab; 2020 May; 33(6):721-728. PubMed ID: 32447331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2months to 2years.
    Berry SA; Longo N; Diaz GA; McCandless SE; Smith WE; Harding CO; Zori R; Ficicioglu C; Lichter-Konecki U; Robinson B; Vockley J
    Mol Genet Metab; 2017 Nov; 122(3):46-53. PubMed ID: 28916119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and laboratory screening studies on urea cycle defects].
    Yang YL; Sun F; Qian N; Song JQ; Wang S; Chang XZ; Yang HY; Wang SQ; Li L; Zhang YH; Bao XH; Li M; Qi Y; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):331-4. PubMed ID: 15924745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen years of urea cycle disorders brain research: Looking back, looking forward.
    Sen K; Whitehead M; Castillo Pinto C; Caldovic L; Gropman A
    Anal Biochem; 2022 Jan; 636():114343. PubMed ID: 34637785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High blood pressure, a red flag for the neonatal manifestation of urea cycle disorders.
    Teufel U; Burgard P; Meyburg J; Lindner M; Poeschl J; Ruef P; Hoffmann GF; Kölker S
    Orphanet J Rare Dis; 2019 Apr; 14(1):80. PubMed ID: 30961665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.